1 / 26

Inna Feldman Uppsala University Inna.feldman@kbh.uu.se

Population prevalence of disease risk factors and economic consequences for the healthcare system - possible scenarios . Inna Feldman Uppsala University Inna.feldman@kbh.uu.se. Estimation of future costs. Compare. Costs. Costs. Costs. Morbidity. Morbidity. Morbidity. Compare.

lona
Download Presentation

Inna Feldman Uppsala University Inna.feldman@kbh.uu.se

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Population prevalence of disease risk factors and economic consequences for the healthcare system- possible scenarios Inna Feldman Uppsala University Inna.feldman@kbh.uu.se

  2. Estimation of future costs Compare Costs Costs Costs Morbidity Morbidity Morbidity Compare Health (risk factors) Health (risk factors) Health (risk factors) Change Present Future Past

  3. Starting points Risk factors: • BMI>30, obesity • Daily smoking • Lack of exercise, physical activity less than 2h/week • Risk alcohol consumption (AUDIT) Source: Population survey Age group: adults, 20-84 years old (4 age groups) Costs: heathcare costs per patient/year Source: Stockholm County´s VAL databases Example for prevalence: • Uppsala County (low risk factors - prevalence) • Sörmland County (high risk factors - prevalence) Base for economic consequences:: lower number of new cases (reduced incidence) due to positive development of risk factors

  4. Disease risk factors Diagnoses:

  5. Risk factors – related risks (RR) • Relative risk (RR) is the risk of an event (or ofdeveloping a disease) relative to exposure. • Relative risk is a ratioof the probabilityof the event occurring in the exposedgroupversus a non-exposedgroup • The model is based on related risks for thesefour risk factors

  6. Risk factors – sources • Swedish and international studies • Age- and gender-specific • Can be updated according to new studies and new results

  7. Relative risks - example Men, 50-64 years old Diagnoses:

  8. Relative risks - example Women, 50-64 years old Diagnoses:

  9. How the change in risk factors influences disease incidence: IF ”Impact fraction” IF is defined as the percent reduction in desease incidence because of reduction of a risk factor prevalence to a certain level IF=[(P2-P1)+RR(P1-P2)]/[(1-P1)+RR*P1] Example: Smoking P1=0,13 (13%) P2=0,1 (10%) Lung cancer • RR=26 IF=0,17 A reduction in smoking rates from 13% to 10% results in a reduction in the incidence of lung cancer by 17%. Stroke • RR=2,6 IF=0,04 A reduction in smoking rates from 13% to 10% results in a reduction in the incidence of stroke by 4%.

  10. The Model Relative risks: Swedish and international scientific studies, gender- and age-specific Incidence: Swedish registers and scientific studies • Prevalence of gender- and age-specific risk factors used to estimate number of new cases • Development of ealier models from Uppsala County • The model can be adapted to different populations by taking into account the existing age structure and the prevalence of risk factors

  11. The costs • Annual health care costs for a person with a respective diagnosis • Based on Stockholm County’s database • Mainly costs for the first year of disease • Did not include medication costs • Can be updated

  12. Time perspective • How long does it take to reduce the risk? • Differs for different diseases and risk factors • Lack of studies Assumption:

  13. Results 1: Uppsala County • The risk factorsdevelopedpositivelywith a reduction in prevalence by 1% for every gender and age group Example: Women, 50-64 years old

  14. Reduction in number of new cases Diagnoses:

  15. Yearly savings If risk factors prevalence decreases by 1%: Expected yearly health care costs of the diseases in Uppsala County: 257MM

  16. Results 1: Sörmland County • The risk factorsdeveloppositivelywith a reduction in prevalence by 1% for every gender and age group Example: Women, 50-64 years old

  17. Reduction in number of new cases Diagnoses:

  18. Yearly savings If risk factors prevalence decreases by 1%: Expected yearly healthcare costs of the diseases in Sörmland County: 237MM

  19. Uppsala - Sörmland: comparison of BMI and smoking

  20. Uppsala - Sörmland: relative savings

  21. Strengths • Can include as many diagnoses as we have data for: • Incidence • Risk factors and RR • Costs • Can be used to calculate other HE-parameters, as QALY • Easy to understand and to use • Can be applied to local data

  22. Weaknesses • Based on the population at baseline, should include population prognosis • Time aspect, more careful estimation • Some risk factors significantly correlate, overestimation • The model estimates only one-year reduction in morbidity, but changes in life style are likely to are affect morbidity for several more years - underestimation

  23. Policy relevance Policy options Risk Factors Disease prevalence Economic consequences

  24. Conclusions • The decrease in the prevalence risk factors can result in significant cost savings for the healthcare system • Relative savings depend on the baseline level of the risk factor which influences the amount of cost savings • The model takes into account only healthcare costs (it can include other societal costs and health effects) • This model may be used in other relevant studies

  25. Development Just now: • Data program with user - friendly interface to make different estimations Coming soon: • Inclusion of other societal costs • Calculation of QALY • Possible to make estimations for different time perspectives

  26. Discussion?

More Related